RESEARCHERS DEVELOP GENE THERAPY METHOD TO TARGET KIDNEY CELLS Findings could lead to improved treatments for kidney diseases.

A synthetic adeno-associated virus was highly efficient at delivering genetic material to different kidney cell types in mice and humans.

The viral vector was also successfully used in gene therapy strategies to treat mice with kidney scarring.